COSAVMO
Live / Allowed — Published for opposition (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99449919
- Mark type
- Stylized text
- Filed
- 17 Oct 2025
- Published for opposition
- 31 Mar 2026
- Attorney of record
- Joshua G. Gigger
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the prevention and treatment of tumorous diseases; pharmaceutical products for the prevention and treatment of myelodysplastic syndromes; pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of myeloproliferative diseases; pharmaceutical products for the prevention and treatment of aggressive systemic mastocytosis; pharmaceutical products for the prevention and treatment of hypereosinophilic syndrome
Owner
- CivicaScript, LLC, Lehi, UT, US
- CivicaScript, LLC, Lehi, UT, US
Prosecution history
- 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Mar 2026 — ASSIGNED TO EXAMINER
- 17 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2025 — NEW APPLICATION ENTERED